The Nasdaq Now: Dramatic Highs and Lows for Peregrine Pharmaceuticals (NASDAQ:PPHM)
Posted on September 25, 2012 at 13:25 PM EDT
MINYANVILLE ORIGINAL It’s a bullish day overall for US markets with investors buoyed by stronger-than-expected housing and consumer confidence reports. The Nasdaq Composite (INDEXNASDAQ:.IXIC) is up a slight notch gaining 0.22% to 3 167.72 on average volume of 791.66 million..   The day’s volume leader thus far is Peregrine Pharmaceuticals (NASDAQ:PPHM) which has had a topsy-turvy day to say the least. After announcing that the phase 2 clinical trial results for its drug bavituximab were not to be trusted Peregrine collapsed and fell as low as $1.23 before dramatically swinging up to $.87. It is at $1.68 (+44.83%) as ...
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here

WHAT'S POPULAR IN THE VILLE

Financial Product Guide